Dr. Gina Natalie Woods, MD

Dr. Woods practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Woods' NPI, 1467401521, was assigned on May 8, 2006. Dr. Woods graduated from Drexel University College Of Medicine in 2001. Dr. Woods holds California license A81848.

Dr. Woods' primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Woods' primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Woods is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health. Dmand AI also links Dr. Woods to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Woods practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Woods' primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Woods is board certified in endocrinology, diabetes and metabolism by the American Board of Internal Medicine. Dr. Woods is licensed in California.

Dmand AI lists enlarged thyroid, hypercalcemia, osteoporosis, overactive thyroid, parathyroid gland disorder, testicular dysfunction and underactive thyroid among the conditions Dr. Woods treats.

CMS data shows 499 Medicare services from Dr. Woods across 4 procedure codes in 2024, for 294 Medicare patients. Medicare paid $37,026 for them. Every service was in an office.

CMS counts 294 Medicare patients who saw Dr. Woods in 2024. The largest group is 65 to 74, with 161 patients. 75% of them have osteoporosis, and 68% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.08, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Woods' median patient age at 70, with 88% women.

In 2024, Dr. Woods wrote 478 Medicare Part D claims for 117 patients. 48% of them were for generic drugs. CMS names the drug for 387 of them, across 7 drugs with 11 or more claims each, at $550,638 in total drug cost. In 2023, CMS named 484 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Woods for performance year 2024, reported as part of a group. Dr. Woods accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Woods as offering telehealth.

Dmand AI links 16 papers to Dr. Woods, published from 2011 to 2025. 2016 was the busiest year, with 2. The most frequent topics are Bone Density, Bone Marrow and Adiposity. Dr. Woods has published most often in J Bone Miner Res. Dr. Woods' most frequent co-authors are Deborah Mitsuko Kado, MD, Anne Louise Schafer, MD and Karen Louise Herbst, MD, PhD.

CMS Open Payments shows 41 general payments to Dr. Woods from 10 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 59% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $16,430.

Dr. Woods graduated from Drexel University College Of Medicine in 2001. Dr. Woods is a member of ACP.

Dr. Woods is in network with 12 carriers, including Aetna, Elevance and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.